nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—HTR2A—vein—ovarian cancer	0.0816	0.109	CbGeAlD
Yohimbine—ADRA1D—epithelium—ovarian cancer	0.034	0.0452	CbGeAlD
Yohimbine—HTR2B—myometrium—ovarian cancer	0.0301	0.0401	CbGeAlD
Yohimbine—ADRA1D—female reproductive system—ovarian cancer	0.0252	0.0336	CbGeAlD
Yohimbine—ADRA2C—myometrium—ovarian cancer	0.0237	0.0315	CbGeAlD
Yohimbine—HTR2B—uterine cervix—ovarian cancer	0.0234	0.0312	CbGeAlD
Yohimbine—HTR2B—decidua—ovarian cancer	0.0223	0.0297	CbGeAlD
Yohimbine—HTR2B—endometrium—ovarian cancer	0.0212	0.0282	CbGeAlD
Yohimbine—HTR2B—uterus—ovarian cancer	0.0195	0.026	CbGeAlD
Yohimbine—HTR1B—female reproductive system—ovarian cancer	0.0195	0.0259	CbGeAlD
Yohimbine—ADRA2A—myometrium—ovarian cancer	0.0189	0.0252	CbGeAlD
Yohimbine—HTR1D—female reproductive system—ovarian cancer	0.0189	0.0251	CbGeAlD
Yohimbine—HTR2C—female reproductive system—ovarian cancer	0.0187	0.0249	CbGeAlD
Yohimbine—ADRA2C—uterine cervix—ovarian cancer	0.0184	0.0245	CbGeAlD
Yohimbine—SLC6A4—female reproductive system—ovarian cancer	0.0177	0.0236	CbGeAlD
Yohimbine—ADRA2C—decidua—ovarian cancer	0.0176	0.0234	CbGeAlD
Yohimbine—HTR2B—female reproductive system—ovarian cancer	0.0175	0.0234	CbGeAlD
Yohimbine—ADRA2C—endometrium—ovarian cancer	0.0167	0.0222	CbGeAlD
Yohimbine—HTR2B—vagina—ovarian cancer	0.0159	0.0211	CbGeAlD
Yohimbine—HTR2A—embryo—ovarian cancer	0.0155	0.0206	CbGeAlD
Yohimbine—ADRA2C—uterus—ovarian cancer	0.0154	0.0205	CbGeAlD
Yohimbine—ADRA2A—uterine cervix—ovarian cancer	0.0147	0.0196	CbGeAlD
Yohimbine—ADRA2A—decidua—ovarian cancer	0.014	0.0187	CbGeAlD
Yohimbine—ADRA2A—endometrium—ovarian cancer	0.0133	0.0177	CbGeAlD
Yohimbine—HTR2A—epithelium—ovarian cancer	0.0126	0.0168	CbGeAlD
Yohimbine—ADRA2C—female gonad—ovarian cancer	0.0126	0.0167	CbGeAlD
Yohimbine—ADRA2C—vagina—ovarian cancer	0.0125	0.0166	CbGeAlD
Yohimbine—ADRA2A—gonad—ovarian cancer	0.0123	0.0164	CbGeAlD
Yohimbine—ADRA2A—uterus—ovarian cancer	0.0123	0.0163	CbGeAlD
Yohimbine—DRD2—testis—ovarian cancer	0.0115	0.0153	CbGeAlD
Yohimbine—ADRA2C—testis—ovarian cancer	0.0111	0.0148	CbGeAlD
Yohimbine—ADRA2A—female reproductive system—ovarian cancer	0.011	0.0147	CbGeAlD
Yohimbine—HTR2A—gonad—ovarian cancer	0.0105	0.014	CbGeAlD
Yohimbine—HTR2B—lymph node—ovarian cancer	0.0103	0.0137	CbGeAlD
Yohimbine—ADRA2A—female gonad—ovarian cancer	0.01	0.0134	CbGeAlD
Yohimbine—ADRA2A—vagina—ovarian cancer	0.00996	0.0133	CbGeAlD
Yohimbine—HTR2A—female reproductive system—ovarian cancer	0.00937	0.0125	CbGeAlD
Yohimbine—ADRA2A—testis—ovarian cancer	0.00889	0.0118	CbGeAlD
Yohimbine—CYP3A4—female reproductive system—ovarian cancer	0.00867	0.0115	CbGeAlD
Yohimbine—CYP2D6—female reproductive system—ovarian cancer	0.00853	0.0114	CbGeAlD
Yohimbine—HTR2A—vagina—ovarian cancer	0.00847	0.0113	CbGeAlD
Yohimbine—ADRA2C—lymph node—ovarian cancer	0.00808	0.0108	CbGeAlD
Yohimbine—CYP2D6—female gonad—ovarian cancer	0.00776	0.0103	CbGeAlD
Yohimbine—HTR2A—testis—ovarian cancer	0.00756	0.0101	CbGeAlD
Yohimbine—CYP2D6—testis—ovarian cancer	0.00689	0.00917	CbGeAlD
Yohimbine—ADRA2A—lymph node—ovarian cancer	0.00644	0.00858	CbGeAlD
Yohimbine—Reserpine—ABCB1—ovarian cancer	9.37e-05	1	CrCbGaD
Yohimbine—ADRA2B—Signaling Pathways—PTEN—ovarian cancer	4.21e-05	0.000169	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CDKN1B—ovarian cancer	4.2e-05	0.000169	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—PIK3CA—ovarian cancer	4.2e-05	0.000169	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—PIK3CA—ovarian cancer	4.19e-05	0.000168	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CCND1—ovarian cancer	4.19e-05	0.000168	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CASP3—ovarian cancer	4.19e-05	0.000168	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—ERBB2—ovarian cancer	4.18e-05	0.000168	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—KRAS—ovarian cancer	4.18e-05	0.000168	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL2—ovarian cancer	4.18e-05	0.000168	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—STAT3—ovarian cancer	4.17e-05	0.000167	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—STAT3—ovarian cancer	4.17e-05	0.000167	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CTNNB1—ovarian cancer	4.17e-05	0.000167	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MYC—ovarian cancer	4.16e-05	0.000167	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—NRAS—ovarian cancer	4.16e-05	0.000167	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—NRAS—ovarian cancer	4.16e-05	0.000167	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—IL6—ovarian cancer	4.16e-05	0.000167	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—AKT1—ovarian cancer	4.16e-05	0.000167	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—KRAS—ovarian cancer	4.15e-05	0.000167	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CTNNB1—ovarian cancer	4.15e-05	0.000167	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.14e-05	0.000166	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PIK3CB—ovarian cancer	4.13e-05	0.000166	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MTOR—ovarian cancer	4.13e-05	0.000166	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CAV1—ovarian cancer	4.13e-05	0.000166	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CASP3—ovarian cancer	4.12e-05	0.000165	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—ERBB2—ovarian cancer	4.12e-05	0.000165	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL2—ovarian cancer	4.11e-05	0.000165	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—AKT1—ovarian cancer	4.11e-05	0.000165	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—KRAS—ovarian cancer	4.1e-05	0.000164	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—IL6—ovarian cancer	4.09e-05	0.000164	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MMP9—ovarian cancer	4.09e-05	0.000164	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CCND1—ovarian cancer	4.07e-05	0.000164	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MAPK1—ovarian cancer	4.07e-05	0.000164	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—EGFR—ovarian cancer	4.07e-05	0.000164	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MMP9—ovarian cancer	4.07e-05	0.000163	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PTEN—ovarian cancer	4.06e-05	0.000163	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MTOR—ovarian cancer	4.06e-05	0.000163	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PIK3CB—ovarian cancer	4.06e-05	0.000163	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PTEN—ovarian cancer	4.04e-05	0.000162	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CTNNB1—ovarian cancer	4.03e-05	0.000162	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CCND1—ovarian cancer	4.01e-05	0.000161	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MAPK3—ovarian cancer	3.98e-05	0.00016	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MAPK3—ovarian cancer	3.98e-05	0.00016	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CTNNB1—ovarian cancer	3.97e-05	0.000159	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CXCL8—ovarian cancer	3.97e-05	0.000159	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—AKT1—ovarian cancer	3.96e-05	0.000159	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MMP9—ovarian cancer	3.96e-05	0.000159	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—AKT1—ovarian cancer	3.94e-05	0.000158	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—HRAS—ovarian cancer	3.94e-05	0.000158	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PTEN—ovarian cancer	3.93e-05	0.000158	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CXCL8—ovarian cancer	3.9e-05	0.000157	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MMP9—ovarian cancer	3.89e-05	0.000156	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—HRAS—ovarian cancer	3.88e-05	0.000156	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CDKN1B—ovarian cancer	3.88e-05	0.000156	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MYC—ovarian cancer	3.88e-05	0.000156	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MYC—ovarian cancer	3.88e-05	0.000156	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PTEN—ovarian cancer	3.87e-05	0.000155	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—KRAS—ovarian cancer	3.85e-05	0.000154	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—PIK3CA—ovarian cancer	3.84e-05	0.000154	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—AKT1—ovarian cancer	3.84e-05	0.000154	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—AKT1—ovarian cancer	3.83e-05	0.000154	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PTEN—ovarian cancer	3.82e-05	0.000153	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—PIK3CA—ovarian cancer	3.81e-05	0.000153	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CDKN1B—ovarian cancer	3.81e-05	0.000153	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—VEGFA—ovarian cancer	3.8e-05	0.000153	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CASP3—ovarian cancer	3.8e-05	0.000152	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL2—ovarian cancer	3.79e-05	0.000152	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MAPK1—ovarian cancer	3.79e-05	0.000152	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MAPK1—ovarian cancer	3.79e-05	0.000152	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—EGFR—ovarian cancer	3.79e-05	0.000152	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—EGFR—ovarian cancer	3.79e-05	0.000152	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—AKT1—ovarian cancer	3.78e-05	0.000152	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—IL6—ovarian cancer	3.77e-05	0.000151	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—AKT1—ovarian cancer	3.77e-05	0.000151	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—STAT3—ovarian cancer	3.76e-05	0.000151	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—PIK3CA—ovarian cancer	3.76e-05	0.000151	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.76e-05	0.000151	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—NRAS—ovarian cancer	3.76e-05	0.000151	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—ERBB2—ovarian cancer	3.75e-05	0.00015	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CASP3—ovarian cancer	3.74e-05	0.00015	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL2—ovarian cancer	3.73e-05	0.00015	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TP53—ovarian cancer	3.72e-05	0.000149	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—IL6—ovarian cancer	3.71e-05	0.000149	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CCND1—ovarian cancer	3.7e-05	0.000148	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PIK3CB—ovarian cancer	3.7e-05	0.000148	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MTOR—ovarian cancer	3.7e-05	0.000148	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.67e-05	0.000147	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—VEGFA—ovarian cancer	3.67e-05	0.000147	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CTNNB1—ovarian cancer	3.66e-05	0.000147	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—VEGFA—ovarian cancer	3.65e-05	0.000147	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TP53—ovarian cancer	3.64e-05	0.000146	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CCND1—ovarian cancer	3.64e-05	0.000146	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—STAT3—ovarian cancer	3.63e-05	0.000146	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—NRAS—ovarian cancer	3.63e-05	0.000146	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—STAT3—ovarian cancer	3.62e-05	0.000145	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—NRAS—ovarian cancer	3.61e-05	0.000145	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CTNNB1—ovarian cancer	3.6e-05	0.000145	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MAPK3—ovarian cancer	3.6e-05	0.000144	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MMP9—ovarian cancer	3.59e-05	0.000144	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—KRAS—ovarian cancer	3.58e-05	0.000144	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—KRAS—ovarian cancer	3.58e-05	0.000144	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PTEN—ovarian cancer	3.57e-05	0.000143	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—HRAS—ovarian cancer	3.56e-05	0.000143	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CXCL8—ovarian cancer	3.55e-05	0.000143	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—VEGFA—ovarian cancer	3.55e-05	0.000143	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—PIK3CA—ovarian cancer	3.54e-05	0.000142	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MMP9—ovarian cancer	3.53e-05	0.000142	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—HRAS—ovarian cancer	3.53e-05	0.000142	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—STAT3—ovarian cancer	3.52e-05	0.000141	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PTEN—ovarian cancer	3.51e-05	0.000141	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—NRAS—ovarian cancer	3.51e-05	0.000141	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MYC—ovarian cancer	3.5e-05	0.00014	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—VEGFA—ovarian cancer	3.5e-05	0.00014	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—HRAS—ovarian cancer	3.48e-05	0.00014	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—AKT1—ovarian cancer	3.48e-05	0.00014	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MAPK3—ovarian cancer	3.47e-05	0.000139	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CDKN1B—ovarian cancer	3.47e-05	0.000139	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—STAT3—ovarian cancer	3.46e-05	0.000139	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MAPK3—ovarian cancer	3.45e-05	0.000139	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—NRAS—ovarian cancer	3.45e-05	0.000139	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—AKT1—ovarian cancer	3.43e-05	0.000138	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	3.43e-05	0.000137	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MAPK1—ovarian cancer	3.42e-05	0.000137	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—EGFR—ovarian cancer	3.42e-05	0.000137	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TP53—ovarian cancer	3.42e-05	0.000137	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.41e-05	0.000137	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—IL6—ovarian cancer	3.4e-05	0.000137	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	3.4e-05	0.000136	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL2—ovarian cancer	3.39e-05	0.000136	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	3.38e-05	0.000136	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MYC—ovarian cancer	3.38e-05	0.000136	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MAPK3—ovarian cancer	3.36e-05	0.000135	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MYC—ovarian cancer	3.36e-05	0.000135	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—TYMS—ovarian cancer	3.35e-05	0.000134	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—IL6—ovarian cancer	3.33e-05	0.000134	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—PIK3CA—ovarian cancer	3.32e-05	0.000133	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	3.31e-05	0.000133	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MAPK3—ovarian cancer	3.31e-05	0.000133	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	3.3e-05	0.000133	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MAPK1—ovarian cancer	3.3e-05	0.000133	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—EGFR—ovarian cancer	3.3e-05	0.000133	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—PIK3CA—ovarian cancer	3.29e-05	0.000132	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—PIK3CA—ovarian cancer	3.29e-05	0.000132	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MAPK1—ovarian cancer	3.29e-05	0.000132	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—EGFR—ovarian cancer	3.29e-05	0.000132	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	3.28e-05	0.000132	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—HRAS—ovarian cancer	3.27e-05	0.000131	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MYC—ovarian cancer	3.27e-05	0.000131	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—KRAS—ovarian cancer	3.23e-05	0.00013	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—VEGFA—ovarian cancer	3.22e-05	0.000129	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MYC—ovarian cancer	3.22e-05	0.000129	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	3.21e-05	0.000129	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MAPK1—ovarian cancer	3.2e-05	0.000128	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—EGFR—ovarian cancer	3.2e-05	0.000128	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	3.19e-05	0.000128	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—STAT3—ovarian cancer	3.19e-05	0.000128	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—NRAS—ovarian cancer	3.18e-05	0.000128	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TP53—ovarian cancer	3.18e-05	0.000128	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TP53—ovarian cancer	3.18e-05	0.000128	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	3.17e-05	0.000127	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MAPK1—ovarian cancer	3.15e-05	0.000126	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—EGFR—ovarian cancer	3.15e-05	0.000126	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—AKT1—ovarian cancer	3.14e-05	0.000126	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—STAT3—ovarian cancer	3.14e-05	0.000126	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—NRAS—ovarian cancer	3.13e-05	0.000126	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IL6—ovarian cancer	3.13e-05	0.000126	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—KRAS—ovarian cancer	3.12e-05	0.000125	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	3.12e-05	0.000125	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—KRAS—ovarian cancer	3.1e-05	0.000125	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—AKT1—ovarian cancer	3.07e-05	0.000123	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MAPK3—ovarian cancer	3.05e-05	0.000122	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—HRAS—ovarian cancer	3.04e-05	0.000122	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—HRAS—ovarian cancer	3.04e-05	0.000122	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—KRAS—ovarian cancer	3.02e-05	0.000121	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	3e-05	0.00012	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—KRAS—ovarian cancer	2.97e-05	0.000119	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—PIK3CA—ovarian cancer	2.97e-05	0.000119	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MYC—ovarian cancer	2.97e-05	0.000119	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MYC—ovarian cancer	2.92e-05	0.000117	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IL6—ovarian cancer	2.91e-05	0.000117	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IL6—ovarian cancer	2.91e-05	0.000117	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MAPK1—ovarian cancer	2.9e-05	0.000116	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—EGFR—ovarian cancer	2.9e-05	0.000116	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—AKT1—ovarian cancer	2.89e-05	0.000116	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	2.88e-05	0.000116	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.88e-05	0.000116	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TP53—ovarian cancer	2.87e-05	0.000115	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PIK3CA—ovarian cancer	2.87e-05	0.000115	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	2.86e-05	0.000115	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	2.85e-05	0.000115	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—EGFR—ovarian cancer	2.85e-05	0.000115	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	2.85e-05	0.000115	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	2.85e-05	0.000114	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PIK3CA—ovarian cancer	2.77e-05	0.000111	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TP53—ovarian cancer	2.77e-05	0.000111	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TP53—ovarian cancer	2.76e-05	0.000111	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—HRAS—ovarian cancer	2.75e-05	0.00011	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—KRAS—ovarian cancer	2.74e-05	0.00011	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PIK3CA—ovarian cancer	2.73e-05	0.00011	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	2.73e-05	0.00011	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—AKT1—ovarian cancer	2.71e-05	0.000109	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CAV1—ovarian cancer	2.7e-05	0.000108	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—KRAS—ovarian cancer	2.7e-05	0.000108	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PIK3CA—ovarian cancer	2.69e-05	0.000108	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—AKT1—ovarian cancer	2.69e-05	0.000108	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—AKT1—ovarian cancer	2.69e-05	0.000108	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TP53—ovarian cancer	2.68e-05	0.000108	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MYC—ovarian cancer	2.65e-05	0.000107	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—HRAS—ovarian cancer	2.65e-05	0.000106	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TP53—ovarian cancer	2.64e-05	0.000106	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—HRAS—ovarian cancer	2.64e-05	0.000106	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IL6—ovarian cancer	2.63e-05	0.000106	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	2.6e-05	0.000104	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	2.6e-05	0.000104	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—HRAS—ovarian cancer	2.57e-05	0.000103	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IL6—ovarian cancer	2.54e-05	0.000102	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—HRAS—ovarian cancer	2.53e-05	0.000101	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IL6—ovarian cancer	2.53e-05	0.000101	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	2.52e-05	0.000101	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PTEN—ovarian cancer	2.49e-05	9.99e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	2.48e-05	9.94e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.46e-05	9.87e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL6—ovarian cancer	2.46e-05	9.86e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	2.45e-05	9.85e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TP53—ovarian cancer	2.44e-05	9.78e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—AKT1—ovarian cancer	2.43e-05	9.74e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL6—ovarian cancer	2.42e-05	9.71e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TP53—ovarian cancer	2.4e-05	9.62e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—AKT1—ovarian cancer	2.34e-05	9.4e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—AKT1—ovarian cancer	2.33e-05	9.35e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HRAS—ovarian cancer	2.33e-05	9.35e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—HRAS—ovarian cancer	2.29e-05	9.2e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—AKT1—ovarian cancer	2.27e-05	9.1e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	2.25e-05	9.05e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—AKT1—ovarian cancer	2.23e-05	8.95e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL6—ovarian cancer	2.23e-05	8.95e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—AKT1—ovarian cancer	2.2e-05	8.84e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL6—ovarian cancer	2.19e-05	8.8e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TP53—ovarian cancer	2.18e-05	8.75e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.16e-05	8.67e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	2.08e-05	8.37e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—AKT1—ovarian cancer	2.06e-05	8.26e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—AKT1—ovarian cancer	2.02e-05	8.12e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL6—ovarian cancer	2e-05	8.01e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.88e-05	7.56e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	1.84e-05	7.39e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.76e-05	7.05e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.63e-05	6.53e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.43e-05	5.76e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.15e-05	4.61e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—AKT1—ovarian cancer	9.38e-06	3.77e-05	CbGpPWpGaD
